Table 2.
Comparison of Lipid Profile, Hormones and Peptides Involved in the Regulation of the Appetite Among All the Groups Using ANOVA and LSD Post Hoc Test
Control N = 3 | NS N = 5 | Ginger N = 5 | NS-Ginger N = 5 | Liraglutide (Saxenda) N = 5 | |
---|---|---|---|---|---|
CCK | 434.8±209.3 | 360.3±84.6 | 332.6±115.8 | 485.3±94.5 | 391.5±111.8 |
Total cholesterol | 1.8±0.4 | 1.2±0.3* p=0.028 | 1.2±0.4* p=0.021 | 1.4±0.5 | 1.1±0.1** p=0.008 |
HDL | 1.3±0.1 | 2.7±0.5* p=0.008 | 1.5±0.6 | 2.5±0.6* p=0.021 | 1.8±0.9 |
Triglycerides | 0.6±0.2 | 0.4±0.2 | 0.3±0.2 | 0.6±0.2 | 0.4±0.1 |
GLP-1 | 354.2±355.3 | 702.1±463.9 | 425.8±523.1 | 167.1±34.9 | 142.7±53.6 |
Ghrelin | 3.0±0.0 | 3.3±0.1* p=0.034 | 3.1±0.3 | 3.3±0.2 P=0.055 | 3.2±0.2 |
GIP | 5. 8±4.2 | 3.8±0.6 | 4.4±0.8 | 3. 8±1.3 | 3.9±0.1 |
Peptide YY | 93.5±17. 8 | 78.6±21.5 | 66.5±23.1 | 63.3±16.1 | 72.0±22.1 |
Orexin | 721.0±141.9 | 604.2±95.5 | 475.7±152.0* p=0.022 | 591.5±96.3 | 615.5±162.0 |
Notes: *P<0.05, **P<0.01.
Abbreviations: CCK, cholecystokinin; HDL, high density lipoprotein; GLP-1, glucagon like peptide-1; GIP, gastric inhibitory polypeptide.